Maker's videoAccuray Incorporated · 5 Feb 2026
Insights from the Global Coalition for Radiotherapy
Against the record
CyberKnife, from Accuray, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 19 Aug 2026: Accuray's new product orders fell to $191.9 million in its 2026 fiscal year, from $288.0 million a year before. The figure covers all of Accuray's machines, not only CyberKnife.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
Join us for an insightful interview with Birgit Fleurent, Deputy Chair of the Board at the Global Coalition for Radiotherapy. Discover how AI is transforming global access to radiotherapy, addressing critical gaps in cancer care, and driving innovation in workflow automation, treatment planning, and quality assurance. Birgit shares expert perspectives on the opportunities and challenges of integrating AI into clinical practice, the importance of equity and local validation, and the strategic priorities shaping the future of AI-enabled radiation oncology. Learn about the collaborative efforts between industry, academia, and governments to ensure safe, effective, and equitable adoption of AI worldwide. To learn more about Accuray and its products, visit https://www.accuray.com/ Follow us on social media! https://twitter.com/Accuray https://www.facebook.com/AccurayIncorporated https://www.…
Written by Accuray Incorporated on YouTube.
